User: prashantiyengar Topic: IP
Category: patents :: india
Last updated: Jun 25 2015 16:43 IST RSS 2.0
 
1 to 20 of 5,443    
TAKE Solutions secures patent for clinical data standardization process 25.6.2015 TOI: Cities
TAKE Solutions -- a Chennai-based global business technology solutions provider -- has been awarded a patent by the United States Patent and Trademark Office (USPTO) for its clinical data standardization ...
Also found in: [+]
India, Japan to sign pact on increasing industrial property cooperation 24.6.2015 ET: Foreign Trade
The Memorandum of Cooperation will be signed between the Department of Industrial Policy and Promotion (DIPP) and the Japan Patent Office (JPO).
Also found in: [+]
Memorandum of Cooperation for bilateral cooperation in the field of Industrial Property for capacity building, human resource development and awareness generation between India and Japan 24.6.2015 Govt of india: PIB
The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, today gave its approval for signing of a Memorandum of Cooperation (MoC) between the Department of Industrial Policy & Promotion (DIPP) and the Japan Patent Office (JPO),
Also found in: [+]
Sensex edges higher, looks set to cross 28,000 mark again 24.6.2015 Sify Finance
Also found in: [+]
Focus on data privacy laws to boost medical outsourcing 23.6.2015 ET: Healthcare
The government should introduce proper regulations for intellectual property and patents besides focusing on implementing data privacy laws, a study said.
Also found in: [+]
Single-window clearance for pharma sector on anvil: Union Minister Ananth Kumar 23.6.2015 DNA: Mumbai
To enable a single-window clearance system in pharmaceuticals sector, the government will set up a high-level committee next week to work out the modalities for the same. The committee will be headed by Pharmaceuticals Secretary V K Subburaj and the move follows a recommendation by the task force on enabling the private sector to lead the growth of the pharmaceuticals sector. "It (committee) will suggest a mechanism for single-window clearance for the pharmaceuticals industry," Chemicals and Fertiliser Minister Ananth Kumar told PTI. Stressing on the importance of having a single authority for clearance in the sector, he said key decision-making powers on various important aspects such "patents, licencing and pricing are with different departments". While the issue of patents is dealt by Department of Industrial Policy & Promotion, drug licence is given by Drug Controller General of India under Health Ministry and pricing is controlled by NPPA, under Pharmaceuticals Department. "This coordination ...
Also found in: [+]
Single-window clearance for pharma sector on anvil: Ananth Kumar 22.6.2015 ET: Policy
To enable a single-window clearance system in pharma sector, govt will set up a high-level committee next week to work out the modalities for the same.
Also found in: [+]
Marking system in Indian education not the right indicator 22.6.2015 ET: Education
It is comforting to imagine that India is intellectually rising because our school grades are getting better every year. However, all indications show that the reverse is actually true.
Also found in: [+]
Chinese firms pour money into US R&D in shift to innovation 21.6.2015 TOI: Intl Business
Surging investment by Chinese companies in U.S. research labs is yielding a fast-growing trove of patents, part of a push to mine America for ideas to help China shift from being the world's factory floor to a driver of innovation.
Also found in: [+]
History of noodles: How they achieved a dominating presence & why they can't be written off 21.6.2015 ET: Food
In just over a century, noodles have been able to achieve a dominating presence in Japan and the world — and despite the current reversal in India, don’t write them off.
Also found in: [+]
US court rejects Teva’s Copaxone patent plea 20.6.2015 TOI: India Business
In a major booster for city-based Natco Pharma, the US Court of Appeals for the Federal Circuit has again struck down Israeli pharma giant Teva Pharmaceutical Industries Ltd’s Copaxone patent, paving the way for Natco Pharma to manufacture the copycat version of the drug subject to the United States Food And Drug Administration (USFDA) nod.
Also found in: [+]
Is yoga a 'Hindu' practice? 19.6.2015 Rediff: Top Stories (India)
In an age of patents and intellectual property rights, it would be improper to deny that yoga comes from the Hindu tradition, says Sankrant Sanu.
Also found in: [+]
Corruption is on retreat in India: US lawmaker 16.6.2015 Rediff: Business
He noted that it would take a long time for turn around the current situation in India
Also found in: [+]
Corruption is on the decline in India, say two US Congressmen 16.6.2015 DNA: Mumbai
While corruption is on the retreat in India, the country needs to act on patent regulations and rule of law, two top US Congressmen said on Tuesday. "Corruption is on the retreat in India. He (Prime Minister Narendra Modi) is trying to bring as much transparency in India as possible," Congressman George Holding, Co-Chair of the powerful Congressional Caucus on India and Indian- Americans, said in his key-note address at a discussion on "Is India Open for Business" organised by the CQ Roll Call and The Economist. "Is India Open for Business? Yes, sure it is," he said as he referred to the series of steps being taken by the Modi Government to improve the ranking of India in Ease of Doing Business. "We still have issues that persist. So far the reforms have not come to fruition," Congressman John Larson said. During his key-note address, Larson, a Democrat, hoped that India would be open for business provided it can get its acts together on patent regulations and rule of law. Referring to his last trip to ...
Also found in: [+]
MNNIT to offer short course in med diagnostics 12.6.2015 TOI: Cities
Motilal Nehru National Institute of Technology (MNNIT) would soon launch a short-term course in bio-entrepreneurship for budding engineers keen to make a career in medical ...
Also found in: [+]
India to resist Japan and South Korea's push for patent legislation at RCEP 12.6.2015 ET: Policy
Japan is pushing for patents to be granted for incremental innovations, even if they don’t show any improved efficacy over an existing invention.
Also found in: [+]
For the record 7.6.2015 The Guardian -- World Latest
“ Bring back the boss class, say employees fed up with self-rule ” (Early editions last week, News, page 20) said in 2007 “a 28-year-old computer programmer, Brian Robertson, came up with and patented the concept of holacracy” [a self-management philosophy]. Mr Robertson was not a programmer but CEO of Ternary Software. He did not patent holacracy but trademarked it. A patent would mean that nobody could use the holacracy model without paying royalties; the trademark only restricts those who would want to sell services using the holacracy brand. In “ The heat and death toll are rising in India ” (In Focus, last week, page 26), we quoted the academic Matthew Huber and said he was at Purdue Climate Change Research Center in Indiana. He is actually affiliated to the Department of Earth Sciences at the University of New ...
Also found in: [+]
Dr AK Dwivedi nominated scientific advisory committee member 5.6.2015 TOI: Cities
The ministry of AYUSH has nominated Gujarati Homeopathic Medical College professor Dr AK Dwivedi as member of scientific advisory committee of Central Homeopathic Research ...
Also found in: [+]
How Ajay Kumar and Somil Daga transformed this Bihar village 5.6.2015 Rediff: Business
Every evening when the lights glow in the huts of Gangapur village, the villagers thank two young men - Ajay Kumar and Somil Daga.
Also found in: [+]
US co Abraxis denied patent on cancer drug 3.6.2015 TOI: India Business
The Indian Patent Office has refused a patent on US firm Abraxis BioSciences’ anti-cancer drug Abraxane, paving the way for generic companies to launch affordable versions in the domestic market. The application on the Abraxane formulation was refused since it lacks inventive step, and violates Section 3 (d) of the Indian Patent Act -- a provision under which Swiss company Novartis lost the patent on its blockbuster cancer drug, Glivec in 2013.
Also found in: [+]
1 to 20 of 5,443